2.9700
+0.2300
+(8.39%)
At close: April 11 at 4:00:01 PM EDT
3.1600
+0.19
+(6.40%)
Pre-Market: 4:10:10 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 11 |
| Avg. Estimate | -0.19 | -0.19 | -0.71 | -0.6 |
| Low Estimate | -0.25 | -0.25 | -0.92 | -1.26 |
| High Estimate | -0.17 | -0.17 | -0.57 | 0.28 |
| Year Ago EPS | -0.23 | -0.23 | -0.86 | -0.71 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 11 |
| Avg. Estimate | -- | -- | 2M | 31.52M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 12M | 118M |
| Year Ago Sales | 235k | -- | 235k | 2M |
| Sales Growth (year/est) | -100.00% | 0.00% | 751.06% | 1,476.03% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.25 | -0.24 | -0.22 | -0.23 |
| EPS Actual | -0.23 | -0.23 | -0.23 | -0.18 |
| Difference | 0.02 | 0.01 | -0.01 | 0.05 |
| Surprise % | 8.00% | 3.36% | -4.55% | 20.35% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.19 | -0.19 | -0.71 | -0.6 |
| 7 Days Ago | -0.19 | -0.19 | -0.71 | -0.6 |
| 30 Days Ago | -0.23 | -0.24 | -0.85 | -0.73 |
| 60 Days Ago | -0.24 | -0.24 | -0.81 | -0.61 |
| 90 Days Ago | -0.25 | -0.25 | -0.8 | -0.61 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 3 | 8 | 7 |
| Up Last 30 Days | 2 | 2 | 9 | 7 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ATYR | 17.87% | 16.91% | 19.88% | 5.26% |
| S&P 500 | 6.76% | 5.77% | 9.23% | 14.19% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/14/2025 |
| Initiated | Leerink Partners: Outperform | 2/18/2025 |
| Initiated | Cantor Fitzgerald: Overweight | 1/6/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/29/2024 |
Related Tickers
NKTR Nektar Therapeutics
0.6177
+23.76%
LXEO Lexeo Therapeutics, Inc.
1.9800
-8.76%
LRMR Larimar Therapeutics, Inc.
1.8100
+1.69%
RCKT Rocket Pharmaceuticals, Inc.
5.27
+6.68%
RZLT Rezolute, Inc.
2.4700
0.00%
SRRK Scholar Rock Holding Corporation
28.00
+6.42%
CMPX Compass Therapeutics, Inc.
1.6950
+2.73%
CMMB Chemomab Therapeutics Ltd.
1.0667
+12.00%
MGTX MeiraGTx Holdings plc
5.20
+2.56%
MIST Milestone Pharmaceuticals Inc.
0.7713
+2.84%